Performance and Impact of the Sepsis ImmunoScore

Sponsor
Prenosis, Inc.
Study ID
NCT07543497
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Sepsis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Sepsis ImmunoScore — DIAGNOSTIC_TEST
    The Sepsis ImmunoScore is a risk stratification tool that uses Artificial Intelligence/Machine Learning to aid in the identification of patients likely to have or progress to sepsis within 24 hours of assessment.

Study Details

The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.

Key Dates

First listed
Apr 22, 2026
Start date
Apr 30, 2026
Status verified
Apr 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Adult patients at risk of clinically significant events
  • Arm: Adult patients suspected of sepsis

Primary Outcome Measure

Sepsis diagnosis [ Time Frame: 24 hours ]

Central Contacts

Related Studies